Pharmacological effects of small molecule BCR-ABL tyrosine kinase inhibitors on platelet function
The Journal of Pharmacology and Experimental Therapeutics · 2025-01 · 392 (1) · 100020
DOI: 10.1124/jpet.124.002104 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pharmacology and Experimental Therapeutics, 2025-01. Verfasst von Yiheng Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, Portland, Oregon. Electronic address: zhangyih@ohsu.edu. Hauptthemen laut MEDLINE: Protein Kinase Inhibitors, Blood Platelets, Fusion Proteins, bcr-abl, Small Molecule Libraries. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, American Society of Hematology, National Heart Lung and Blood Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, Portland, Oregon. Electronic address: zhangyih@ohsu.edu.
- Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, Portland, Oregon.
- Knight Cardiovascular Institute, School of Medicine, Oregon Health & Science University, Portland, Oregon.
- Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, Portland, Oregon; Knight Cardiovascular Institute, School of Medicine, Oregon Health & Science University, Portland, Oregon.
- Enliven Therapeutics, Inc, Boulder, Colorado.
- Department of Biomedical Engineering, School of Medicine, Oregon Health & Science University, Portland, Oregon; Division of Hematology & Medical Oncology, School of Medicine, Oregon Health & Science University, Portland…
Förderung
- NHLBI NIH HHS
- American Society of Hematology
- National Heart Lung and Blood Institute
- American Heart Association Inc
Zitieren
APA
Zhang, Y., Yang, C. J., Melrose, A. R., Pang, J., Schofield, K., Song, S. D., Parra-Izquierdo, I., Zheng, T. J., Lyssikatos, J. P., Gross, S. D., Shatzel, J. J., McCarty, O. J. T., & Aslan, J. E. (2025). Pharmacological effects of small molecule BCR-ABL tyrosine kinase inhibitors on platelet function. The Journal of Pharmacology and Experimental Therapeutics, 392(1), 100020. https://doi.org/10.1124/jpet.124.002104
Vancouver
Zhang Y, Yang CJ, Melrose AR, Pang J, Schofield K, Song SD, et al. Pharmacological effects of small molecule BCR-ABL tyrosine kinase inhibitors on platelet function. The Journal of Pharmacology and Experimental Therapeutics. 2025;392(1):100020. doi:10.1124/jpet.124.002104
BibTeX
@article{Zhang2025,
author = {Zhang, Yiheng and Yang, Chih-Jen and Melrose, Alexander R and Pang, Jiaqing and Schofield, Kirrali and Song, Serena D and Parra-Izquierdo, Iván and Zheng, Tony J and Lyssikatos, Joseph P and Gross, Stefan D and Shatzel, Joseph J and McCarty, Owen J T and Aslan, Joseph E},
title = {Pharmacological effects of small molecule BCR-ABL tyrosine kinase inhibitors on platelet function},
journal = {The Journal of Pharmacology and Experimental Therapeutics},
year = {2025},
volume = {392},
number = {1},
pages = {100020},
doi = {10.1124/jpet.124.002104}
}
EUVIMED